Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.

Gastroenterology - 1 Feb 2003

Promrat Kittichai, McDermott David H, Gonzalez Carlos M, Kleiner David E, Koziol Deloris E, Lessie Matthew, Merrell Maya, Soza Alejandro, Heller Theo, Ghany Marc, Park Yoon, Alter Harvey J, Hoofnagle Jay H, Murphy Philip M, Liang T Jake

Abstract excerpt

BACKGROUND & AIMS: CCR5Delta32, a 32-base pair deletion of the CC chemokine receptor (CCR) 5 gene, is associated with slowed human immunodeficiency virus disease progression in heterozygotes and protection against infection in homozygotes. A recent study found a higher than expected frequency of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Chemokine CCL5

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferons

Share to Liver Cirrhosis

Share to Receptors, CCR2

Share to Receptors, CCR5

Share to Receptors, Chemokine

Source

Identifiers

PMID: 12557141
DOI: 10.1053/gast.2003.50061

Genes

CCR5
CCR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-12557141-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.PMID 12557141Read ↗

The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.Semantic proximity Read ↗

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.Semantic proximity Read ↗

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection.Semantic proximity Read ↗

Clinical significance of the CCR5delta32 allele in hepatitis C.Semantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.Semantic proximity Read ↗

CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.Semantic proximity Read ↗

Phenotypic expressions of CCR5-delta32/delta32 homozygosity.Semantic proximity Read ↗

Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.Semantic proximity Read ↗

The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection.Semantic proximity Read ↗

CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis.Semantic proximity Read ↗

Lack of higher frequency of the chemokine receptor 5-delta32/delta32 genotype in hepatitis C.Semantic proximity Read ↗

CCR5Delta32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.